UPC CFI 195/2025
Feb 28, 2025·EP4252857 +1 more: METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)
- Case details
- StatusCase ClosedActionInfringementCategoryMain Infringement Action
- Parties
- ClaimantsReps: Niels Hölder (Hoffmann Eitle); Mike Gruber (Hoffmann Eitle); Michael Pfeifer (Hoffmann Eitle); Daniel Wise (Carpmaels & Ransford); Agathe Michel-De Cazotte (Carpmaels & Ransford)RespondentsReps: Johannes Heselberger (Bardehle Pagenberg); Nadine Westermeyer (Bardehle Pagenberg)
- Division
- Dusseldorf LD
- Technology
- Pharmaceuticals · Antibody Therapy · Organic Chemistry
- Language
- English
- First decided
- Jun 8, 2026
- 2026-06-08WithdrawnInfringement meritsInfringement Action
Both the claimants' infringement action and the defendants' counterclaim for revocation were withdrawn before closure of the written procedure. The court permitted both withdrawals, declared proceedings closed, and ordered 50% reimbursement of court fees to both parties.
Legal issues:Withdrawal of infringement action (R. 265 RoP)Withdrawal of counterclaim for revocationReimbursement of court fees on withdrawal (R. 370.9 RoP)Lifting of stay of proceedingsDamages: - 2025-08-06Generic application
The Düsseldorf Local Division granted the claimants' request to stay infringement proceedings (and the related counterclaim for revocation) concerning EP 4 252 857 pending the outcome of the appeal against the first-instance decision in related case UPC_CFI_505/2024 (concerning EP 3 536 712). The court found that both cases involve the same factual and legal infringement questions and that a stay serves efficient use of judicial and party resources.
Legal issues:Stay of proceedings (R. 295(m) RoP)Related infringement proceedings involving same legal and factual questionsEfficient administration of justice
| Document title | Date | Public |
|---|---|---|
| action.phaseChange.caseClose | 2026-06-08 | Not public |
| Other Documents | 2026-06-08 | Public |
| Receipt | 2026-03-12 | Not public |
| Cover sheet | 2026-03-12 | Not public |
| Document Defendant | 2026-03-12 | Not public |
| Receipt | 2026-03-11 | Not public |
| Cover sheet | 2026-03-11 | Not public |
| Application document Claimant | 2026-03-11 | Not public |
| Outcome of the Order | 2025-08-06 | Not public |
| Closing of the workflow | 2025-08-06 | Public |
| Outcome of the Order | 2025-08-06 | Not public |
| Closing of the workflow | 2025-08-06 | Public |
| Headnote-and-Keywords | 2025-08-06 | Not public |
| Outcome of the Order | 2025-08-06 | Not public |
| R. 295 (m) RoP Order - Stay of proceedings | 2025-08-06 | Public |
| Receipt | 2025-08-05 | Not public |
| On Amgens comments to the time extension request | 2025-08-05 | Not public |
| 20250729_Response_to_time_extension_request_Amgen_EN_signed | 2025-07-29 | Not public |
| Opportunity to comment | 2025-07-22 | Not public |
| Receipt | 2025-07-21 | Not public |
| Application for extension of time period | 2025-07-18 | Not public |
| Response to stay request | 2025-06-30 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-06-27 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-06-27 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-06-27 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-06-27 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-06-27 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-06-27 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-06-27 | Not public |
| Acknowledgement-of-lodging | 2025-06-24 | Not public |
| Acknowledgement-of-lodging | 2025-06-24 | Not public |
| Acknowledgement-of-lodging | 2025-06-24 | Not public |
| Acknowledgement-of-lodging | 2025-06-24 | Not public |
| Acknowledgement-of-lodging | 2025-06-24 | Not public |
| Acknowledgement-of-lodging | 2025-06-24 | Not public |
| Acknowledgement-of-lodging | 2025-06-24 | Not public |
| 20250624_Statement_of_Defence_and_Counterclaim_Amgen_en_signed | 2025-06-24 | Not public |
| SoD_Brief_re_Exhibits_Amgen_EN | 2025-06-24 | Not public |
| SoD_Brief_re_Exhibits_Amgen_EN | 2025-06-24 | Not public |
| 20250624_Statement_of_Defence_and_Counterclaim_Amgen_en_signed | 2025-06-24 | Not public |
| 20250624_Statement_of_Defence_and_Counterclaim_Amgen_en_signed | 2025-06-24 | Not public |
| SoD_Brief_re_Exhibits_Amgen_EN | 2025-06-24 | Not public |
| 20250624_Statement_of_Defence_and_Counterclaim_Amgen_en | 2025-06-24 | Not public |
| SoD_Brief_re_Exhibits_Amgen_EN | 2025-06-24 | Not public |
| SoD_Brief_re_Exhibits_Amgen_EN | 2025-06-24 | Not public |
| Statement_of_Defence_and_Counterclaim_Amgen_en | 2025-06-24 | Not public |
| SoD_Brief_re_Exhibits_Amgen_EN | 2025-06-24 | Not public |
| Statement_of_Defence_and_Counterclaim_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP87_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP143_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP106_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP10_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP128d_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP18_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP51a_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP84_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP117_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP33_Amgen_de | 2025-06-24 | Not public |
| Exhibit_BP35_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP11_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP65_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP15_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP93_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP64_Amgen_de | 2025-06-24 | Not public |
| Exhibit_BP57_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP128a_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP31_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP137_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP140_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP53a_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP125_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP42_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP60_Amgen_de | 2025-06-24 | Not public |
| Exhibit_BP61_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP115_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP00_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP134_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP126_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP131_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP76a_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP06_part_4_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP112_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP48_Amgen_fr | 2025-06-24 | Not public |
| Exhibit_BP109_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP128b_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP63a_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP110_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP16_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP47_Amgen_nl | 2025-06-24 | Not public |
| 20250624_Statement_of_Defence_and_Counterclaim_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP132_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP102_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP09_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP68_Amgen_it | 2025-06-24 | Not public |
| Exhibit_BP56_part_2_Amgen_fr | 2025-06-24 | Not public |
| Exhibit_BP136_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP103_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP89_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP53_Amgen_de | 2025-06-24 | Not public |
| Exhibit_BP77_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP63b_Amgen_de | 2025-06-24 | Not public |
| Exhibit_BP46_Amgen_nl | 2025-06-24 | Not public |
| Exhibit_BP98_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP48a_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP142_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP124_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP108_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP128c_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP37_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP51_Amgen_it | 2025-06-24 | Not public |
| Exhibit_BP39_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP36_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP66_Amgen_nl | 2025-06-24 | Not public |
| Exhibit_BP90_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP135_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP76_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP96_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP50a_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP50_Amgen_fr | 2025-06-24 | Not public |
| Exhibit_BP130_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP60a_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP90a_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP144_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP113_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP64a_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP97_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP44_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP75_Amgen_de | 2025-06-24 | Not public |
| Exhibit_BP14_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP49a_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP55_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP86_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP70_Amgen_de | 2025-06-24 | Not public |
| Exhibit_BP69_Amgen_be | 2025-06-24 | Not public |
| Exhibit_BP138_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP133_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP52a_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP95_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP127_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP120_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP67a_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP54_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP100_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP121_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP47a_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP91_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP41_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP62_Amgen_de | 2025-06-24 | Not public |
| Exhibit_BP116_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP06_part_2_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP105_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP111_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP66a_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP43_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP05_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP139_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP75a_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP56a_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP59_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP13_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP107_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP56_part_1_Amgen_fr | 2025-06-24 | Not public |
| Exhibit_BP38_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP33a_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP118_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP123_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP141_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP08_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP104_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP80_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP46a_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP119_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP58_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP114_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP94_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP19_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP99_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP49_Amgen_fr | 2025-06-24 | Not public |
| Exhibit_BP32_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP63_Amgen_de | 2025-06-24 | Not public |
| Exhibit_BP17_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP101_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP122_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP06_part_1_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP70a_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP34a_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP68a_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP69a_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP129_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP52_Amgen_de | 2025-06-24 | Not public |
| Exhibit_BP34_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP78_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP06_part_3_Amgen_en | 2025-06-24 | Not public |
| Exhibit_BP92_Amgen_EN | 2025-06-24 | Not public |
| Exhibit_BP67_Amgen_fr | 2025-06-24 | Not public |
| Opportunity to comment | 2025-06-10 | Not public |
| Receipt | 2025-06-10 | Not public |
| Application | 2025-06-09 | Not public |
| Outcome of the Order | 2025-05-02 | Not public |
| Extension of deadlines | 2025-05-02 | Public |
| Comments on Request for time extension (signed) | 2025-05-01 | Not public |
| Comments on Request for time extension | 2025-04-30 | Not public |
| Opportunity to comment | 2025-04-17 | Not public |
| Receipt | 2025-04-15 | Not public |
| 20250415_Time_extension_request_Amgen_en | 2025-04-15 | Not public |
| communicationCheck | 2025-03-06 | Not public |
| communicationCheck | 2025-03-06 | Not public |
| communicationCheck | 2025-03-06 | Not public |
| Document from EPO | 2025-03-05 | Not public |
| Document from EPO | 2025-03-05 | Not public |
| Document from EPO | 2025-03-05 | Not public |
| communicationCheck | 2025-03-05 | Not public |
| Document from EPO | 2025-03-05 | Not public |
| communicationCheck | 2025-03-05 | Not public |
| Document from EPO | 2025-03-05 | Not public |
| communicationCheck | 2025-03-05 | Not public |
| Document from EPO | 2025-03-05 | Not public |
| communicationCheck | 2025-03-05 | Not public |
| Document from EPO | 2025-03-04 | Not public |
| Acknowledgement of access to case | 2025-03-03 | Not public |
| Notification Of Service | 2025-03-03 | Not public |
| Acknowledgement of access to case | 2025-03-03 | Not public |
| Notification Of Service | 2025-03-03 | Not public |
| Acknowledgement of access to case | 2025-03-03 | Not public |
| Notification Of Service | 2025-03-03 | Not public |
| Acknowledgement of access to case | 2025-03-03 | Not public |
| Notification Of Service | 2025-03-03 | Not public |
| Acknowledgement of access to case | 2025-03-03 | Not public |
| Notification Of Service | 2025-03-03 | Not public |
| Acknowledgement of access to case | 2025-03-03 | Not public |
| Notification Of Service | 2025-03-03 | Not public |
| Acknowledgement of access to case | 2025-03-03 | Not public |
| Notification Of Service | 2025-03-03 | Not public |
| Panel-Appointment | 2025-03-03 | Not public |
| EPO-Request-for-case-pending | 2025-03-03 | Not public |
| Receipt | 2025-03-03 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-03-03 | Not public |
| Acknowledgement-of-lodging | 2025-02-28 | Not public |
| 2025.02.28 Additional brief EP 857 - signed | 2025-02-28 | Not public |
| HE 62 | 2025-02-28 | Not public |
| HE 55 | 2025-02-28 | Not public |
| HE 23 | 2025-02-28 | Not public |
| HE 55 | 2025-02-28 | Not public |
| HE 37 | 2025-02-28 | Not public |
| HE 63 | 2025-02-28 | Not public |
| HE 128 | 2025-02-28 | Not public |
| HE 34 | 2025-02-28 | Not public |
| HE 130 | 2025-02-28 | Not public |
| HE 16 | 2025-02-28 | Not public |
| HE 57 | 2025-02-28 | Not public |
| HE 46 | 2025-02-28 | Not public |
| HE 117 | 2025-02-28 | Not public |
| HE 119 | 2025-02-28 | Not public |
| HE 109 | 2025-02-28 | Not public |
| HE 128 | 2025-02-28 | Not public |
| HE 105 | 2025-02-28 | Not public |
| HE 116 | 2025-02-28 | Not public |
| HE 15 | 2025-02-28 | Not public |
| HE 12 | 2025-02-28 | Not public |
| HE 13 | 2025-02-28 | Not public |
| HE 99 | 2025-02-28 | Not public |
| HE 132 | 2025-02-28 | Not public |
| Proof of payment | 2025-02-28 | Not public |
| HE 31 | 2025-02-28 | Not public |
| HE 120 | 2025-02-28 | Not public |
| HE 58a | 2025-02-28 | Not public |
| HE 30 | 2025-02-28 | Not public |
| HE 118 | 2025-02-28 | Not public |
| HE 126 | 2025-02-28 | Not public |
| Evidence of reduced court fee of EUR 225,000 (Orders of 2025.01.30 and 2025.02.03) | 2025-02-28 | Not public |
| HE 133 | 2025-02-28 | Not public |
| HE 26 | 2025-02-28 | Not public |
| HE 122 | 2025-02-28 | Not public |
| HE 49 | 2025-02-28 | Not public |
| HE 64 | 2025-02-28 | Not public |
| HE 130 | 2025-02-28 | Not public |
| HE 60 | 2025-02-28 | Not public |
| HE 47 | 2025-02-28 | Not public |
| HE 21 | 2025-02-28 | Not public |
| HE 104 | 2025-02-28 | Not public |
| HE 35 | 2025-02-28 | Not public |
| HE 96 | 2025-02-28 | Not public |
| HE 129 | 2025-02-28 | Not public |
| HE 132 | 2025-02-28 | Not public |
| HE 57 | 2025-02-28 | Not public |
| HE 98 | 2025-02-28 | Not public |
| HE 127 | 2025-02-28 | Not public |
| 2024.09.25 EP857 Application to Extend - signed | 2025-02-28 | Not public |
| HE 26 | 2025-02-28 | Not public |
| HE 124 | 2025-02-28 | Not public |
| HE 05 | 2025-02-28 | Not public |
| HE 33 | 2025-02-28 | Not public |
| HE 18 | 2025-02-28 | Not public |
| HE 131 | 2025-02-28 | Not public |
| HE 58 | 2025-02-28 | Not public |
| HE 107 | 2025-02-28 | Not public |
| HE 07 | 2025-02-28 | Not public |
| HE 97 | 2025-02-28 | Not public |
| HE 121 | 2025-02-28 | Not public |
| HE 125 | 2025-02-28 | Not public |
| HE 25 | 2025-02-28 | Not public |
| HE 116a | 2025-02-28 | Not public |
| HE 17 | 2025-02-28 | Not public |
| HE 106 | 2025-02-28 | Not public |
| HE 42 | 2025-02-28 | Not public |
| HE 108 | 2025-02-28 | Not public |
| HE 82 | 2025-02-28 | Not public |
| HE 47 | 2025-02-28 | Not public |
| HE 28 | 2025-02-28 | Not public |
| HE 36 | 2025-02-28 | Not public |
| HE 116a | 2025-02-28 | Not public |
| HE 27 | 2025-02-28 | Not public |
| HE 42 | 2025-02-28 | Not public |
| HE 123 | 2025-02-28 | Not public |
| HE 25 | 2025-02-28 | Not public |
| HE 20 | 2025-02-28 | Not public |